Lisa Maier
Lisa Maier
EMBL Heidelberg
Verified email at
Cited by
Cited by
Extensive impact of non-antibiotic drugs on human gut bacteria
L Maier, M Pruteanu, M Kuhn, G Zeller, A Telzerow, EE Anderson, ...
Nature 555 (7698), 623-628, 2018
Salt-responsive gut commensal modulates TH 17 axis and disease
N Wilck, MG Matus, SM Kearney, SW Olesen, K Forslund, ...
Nature 551 (7682), 585-589, 2017
Gut inflammation can boost horizontal gene transfer between pathogenic and commensal Enterobacteriaceae
B Stecher, R Denzler, L Maier, F Bernet, MJ Sanders, DJ Pickard, ...
Proceedings of the National Academy of Sciences 109 (4), 1269-1274, 2012
'Blooming'in the gut: how dysbiosis might contribute to pathogen evolution
B Stecher, L Maier, WD Hardt
Nature Reviews Microbiology 11 (4), 277-284, 2013
Stabilization of cooperative virulence by the expression of an avirulent phenotype
M Diard, V Garcia, L Maier, MNP Remus-Emsermann, RR Regoes, ...
Nature 494 (7437), 353-356, 2013
Glycosylation of wall teichoic acid in Staphylococcus aureus by TarM.
G Xia, L Maier, P Sanchez-Carballo, M Li, M Otto, O Holst, A Peschel
J Biol Chem. 2010, 2010
Microbiota-Derived Hydrogen Fuels Salmonella Typhimurium Invasion of the Gut Ecosystem
L Maier, R Vyas, CD Cordova, H Lindsay, TSB Schmidt, S Brugiroux, ...
Cell host & microbe 14 (6), 641-651, 2013
Granulocytes impose a tight bottleneck upon the gut luminal pathogen population during Salmonella typhimurium colitis
L Maier, M Diard, ME Sellin, ES Chouffane, K Trautwein-Weidner, ...
PLoS Pathog 10 (12), e1004557, 2014
Systematically investigating the impact of medication on the gut microbiome
L Maier, A Typas
Current opinion in microbiology 39, 128-135, 2017
Salmonella Typhimurium strain ATCC14028 requires H 2-hydrogenases for growth in the gut, but not at systemic sites
L Maier, M Barthel, B Stecher, RJ Maier, JS Gunn, WD Hardt
PloS one 9 (10), e110187, 2014
Live attenuated S. Typhimurium vaccine with improved safety in immuno-compromised mice
B Periaswamy, L Maier, V Vishwakarma, E Slack, M Kremer, ...
PLoS One 7 (9), e45433, 2012
Peroral ciprofloxacin therapy impairs the generation of a protective immune response in a mouse model for Salmonella enterica serovar Typhimurium diarrhea, while parenteral …
K Endt, L Maier, R Käppeli, M Barthel, B Misselwitz, M Kremer, WD Hardt
Antimicrobial agents and chemotherapy 56 (5), 2295-2304, 2012
Escherichia coli limits Salmonella Typhimurium infections after diet shifts and fat-mediated microbiota perturbation in mice
SY Wotzka, M Kreuzer, L Maier, M Arnoldini, BD Nguyen, AO Brachmann, ...
Nature microbiology 4 (12), 2164-2174, 2019
Microbiota stability in healthy individuals after single-dose lactulose challenge—A randomized controlled study
SY Wotzka, M Kreuzer, L Maier, M Zünd, M Schlumberger, B Nguyen, ...
PloS one 13 (10), e0206214, 2018
Dissecting the collateral damage of antibiotics on gut microbes
L Maier, CV Goemans, M Pruteanu, J Wirbel, M Kuhn, E Cacace, ...
BioRxiv, 2020
Komplexe Wechselwirkungen zwischen Arzneimitteln und dem Mikrobiom
L Maier
BIOspektrum 25 (7), 707-710, 2019
Correction: Granulocytes Impose a Tight Bottleneck upon the Gut Luminal Pathogen Population during Salmonella Typhimurium Colitis ((2015), 11, 7)
L Maier, M Diard, ME Sellin, ES Chouffane, K Trautwein-Weidner, ...
The role of the intestinal microbiota in enteric Salmonella typhimurium infection
LB Maier
ETH Zurich, 2013
3. Chapter III-Methods to study the replication of Salmonella Typhimurium in vivo
B Felmy, ME Sellin, MRJ Diard, LB Maier, M Furter, L Hemmerle, ...
Mechanistic analysis of pathogen-host interactions in Salmonella-induced …, 0
The system can't perform the operation now. Try again later.
Articles 1–19